Skip to content
Monday, November 9, 2026
Stay informed with the latest UK news, technology trends, a…

Giving Pluripotent Cells During Pregnancy to Babies with Spina Bifida Enhances Life Outcomes, Trial Finds

An innovative research effort has revealed that delivering regenerative cells to developing infants suffering from spina bifida while undergoing fetal surgery could constitute a "major milestone" in managing prenatal disorders.

Research Framework and Assurance

The American study focused on six developing infants with myelomeningocele. Surgeons applied regenerative cells sourced from the maternal placenta directly onto the developing neural column while the defect was being closed.

Critically, the cell therapy demonstrated a favorable safety profile. Doctors verified that the therapy did not induce tumors, hinder surgical recovery, or prevent the reversal of associated brain abnormalities.

Promising Outcomes

Post-birth MRI scans indicated a complete reversal of brainstem displacement in all six infants. This neurological improvement is closely linked to improved motor skills and quality of life.

"Should it enable additional babies to achieve ambulation who previously could not, it could establish itself as their standard of care," said the lead researcher. "These findings are extremely promising and pave the way for a variety of prospective new treatments."

Future Implications and Hope

Independent medical specialists indicated that additional validation of these noted improvements could signal a "different age" in fetal surgery. The potential to improve neurological damage occurring during fetal development is viewed as a revolutionary objective.

Especially significant would be advancements for continence and digestive health, which are common challenges for individuals living with this condition.

Looking Ahead

Although this preliminary study focused on a handful of cases, its confirmed tolerability and hopeful trends offer a robust platform for larger, more comprehensive studies. The integration of stem cell therapy with proven prenatal surgical methods presents significant potential for improving the prognosis for babies yet to be born with spina bifida.

The writer

Jennifer Hall

A UK-based journalist and tech enthusiast, Eleanor covers media trends and digital culture with a focus on British perspectives.

Update Brit Media

Type to search articles.